Russell Beyer
Directeur Financier/CFO chez SAB Sciences, Inc.
Fortune : 771 $ au 31/05/2024
Profil
Russell P.
Beyer is currently the Chief Financial Officer at SAB Sciences, Inc. He previously held the same position at SAB Biotherapeutics, Inc. from 2021 to 2023.
Prior to that, he was the Chief Financial Officer at Big Cypress Acquisition Corp.
Mr. Beyer received an undergraduate degree from St. Lawrence University and an MBA from the University of Rochester Simon Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/03/2023 | 292 ( 0,00% ) | 771 $ | 31/05/2024 |
Postes actifs de Russell Beyer
| Sociétés | Poste | Début |
|---|---|---|
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Directeur Financier/CFO | 01/09/2021 |
Anciens postes connus de Russell Beyer
| Sociétés | Poste | Fin |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Directeur Financier/CFO | 27/10/2023 |
| BIG CYPR | Directeur Financier/CFO | - |
Formation de Russell Beyer
| University of Rochester Simon Business School | Masters Business Admin |
| St. Lawrence University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Big Cypress Acquisition Corp.
 Big Cypress Acquisition Corp. Financial ConglomeratesFinance Big Cypress Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on November 12, 2020 and is headquartered in Miami Beach, FL. | Finance |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Health Technology |
